Affimed Logo
  • Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • Pipeline and Clinical Trials
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners
  • News and Events
  • Innately Affimed
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Corporate Governance Affimed
    • Annual General Meeting 2023
    • Sustainability Affimed
    • Press Release Distribution
  • Careers
    • Culture
  • Contact
Menu

News and Events

See what’s new at Affimed

News

All categories
Earnings
Press Release
All years
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Affimed to Present at the UBS Global Healthcare Conference –New York

May 17, 2016

Affimed to Present at the Cowen and Company 36th Annual Health Care Conference

February 29, 2016

Affimed to Speak at Symposium on Emerging Approaches in Cancer Immunotherapy

February 22, 2016

Affimed to Present at the Leerink Partners 5th Annual Global Healthcare Conference

February 4, 2016

Affimed Enters into Collaboration with Merck to Evaluate AFM13 in Combination with KEYTRUDA® (pembrolizumab) for Patients with Hodgkin Lymphoma

January 25, 2016

Affimed Appoints Dr. Joerg Windisch as Chief Operating Officer and Adds Dr. Bernhard Ehmer to Supervisory Board

January 21, 2016

Affimed to Host Hodgkin’s Lymphoma Day with Key Opinion Leaders on January 26th in New York City

January 20, 2016

Affimed to Present at Noble Financial Capital Markets’ 12th Annual Investor Conference

January 12, 2016

Affimed Added to NASDAQ Biotech Index®

December 14, 2015

Affimed Presents Additional Data on Combination of AFM13 with Checkpoint Inhibitors at ASH

December 6, 2015

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30

Events

All
Scientific
Investors

26Sep

NK2023

September 26 - 29, 2023 (Oslo, Norway)

WebcastsMore events

Affimed GmbH
Gottlieb-Daimler Straße 2
68165 Mannheim
Germany

Phone: +49 (0)621-56003-0
Fax: +49 (0)621-56003-649
email hidden; JavaScript is required

  • Affimed Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners
  • News and Events
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Press Release Distribution
    • Corporate Governance
  • Careers
    • Culture

© 2023 Affimed GmbH

  • Data Protection
  • Imprint
  • Contact